Evidence map›Paper›PMID 39560287›Full record

ArticleThe Biochemical journal2024

On the function of TRAP substrate-binding proteins: the isethionate-specific binding protein IseP.

Michael C Newton-Vesty, Michael J Currie, James S Davies, Santosh Panjikar, Ashish Sethi, Andrew E Whitten, Zachary D Tillett, David M Wood, Joshua D Wright, Michael J Love and 5 more

Abstract read
In one paragraph

Article in The Biochemical journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Michael C Newton-VestyBiomolecular Interaction Centre, School of Biological Sciences, MacDiarmid Institute for Advanced Materials and Nanotechnology, University of Canterbury, Christchurch 8140, New Zealand.ORCID 0009-0001-8353-8169
Michael J CurrieBiomolecular Interaction Centre, School of Biological Sciences, MacDiarmid Institute for Advanced Materials and Nanotechnology, University of Canterbury, Christchurch 8140, New Zealand.
James S DaviesBiomolecular Interaction Centre, School of Biological Sciences, MacDiarmid Institute for Advanced Materials and Nanotechnology, University of Canterbury, Christchurch 8140, New Zealand.
Santosh PanjikarAustralian Synchrotron, Australian Nuclear Science and Technology Organisation (ANSTO), 800 Blackburn Road, Clayton, Victoria 3168, Australia.
Ashish SethiAustralian Synchrotron, Australian Nuclear Science and Technology Organisation (ANSTO), 800 Blackburn Road, Clayton, Victoria 3168, Australia.
Andrew E WhittenAustralian Centre for Neutron Scattering (ACNS), ANSTO, Lucas Heights, New South Wales 2234, Australia.
Zachary D TillettBiomolecular Interaction Centre, School of Biological Sciences, MacDiarmid Institute for Advanced Materials and Nanotechnology, University of Canterbury, Christchurch 8140, New Zealand.
David M WoodBiomolecular Interaction Centre, School of Biological Sciences, MacDiarmid Institute for Advanced Materials and Nanotechnology, University of Canterbury, Christchurch 8140, New Zealand.
Joshua D WrightBiomolecular Interaction Centre, School of Biological Sciences, MacDiarmid Institute for Advanced Materials and Nanotechnology, University of Canterbury, Christchurch 8140, New Zealand.
Michael J LoveBiomolecular Interaction Centre, School of Biological Sciences, MacDiarmid Institute for Advanced Materials and Nanotechnology, University of Canterbury, Christchurch 8140, New Zealand.
Timothy M AllisonBiomolecular Interaction Centre, School of Physical and Chemical Sciences, University of Canterbury, Christchurch 8140, New Zealand.ORCID 0000-0003-4100-6700
Sam A JamiesonBiochemistry Department, School of Biomedical Sciences, University of Otago, Dunedin 9054, New Zealand.
Peter D MaceBiochemistry Department, School of Biomedical Sciences, University of Otago, Dunedin 9054, New Zealand.
Rachel A NorthSchool of Medical Sciences, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales 2006, Australia.
Renwick C J DobsonBiomolecular Interaction Centre, School of Biological Sciences, MacDiarmid Institute for Advanced Materials and Nanotechnology, University of Canterbury, Christchurch 8140, New Zealand.ORCID 0000-0002-5506-4939

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacteria evolve mechanisms to compete for limited resources and survive in new niches. Here we study the mechanism of isethionate import from the sulfate-reducing bacterium Oleidesulfovibrio alaskensis. The catabolism of isethionate by Desulfovibrio species has been implicated in human disease, due to hydrogen sulfide production, and has potential for industrial applications. O. alaskensis employs a tripartite ATP-independent periplasmic (TRAP) transporter (OaIsePQM) to import isethionate, which relies on the substrate-binding protein (OaIseP) to scavenge isethionate and deliver it to the membrane transporter component (OaIseQM) for import into the cell. We determined the binding affinity of isethionate to OaIseP by isothermal titration calorimetry, KD = 0.95 µM (68% CI = 0.6-1.4 µM), which is weaker compared with other TRAP substrate-binding proteins. The X-ray crystal structures of OaIseP in the ligand-free and isethionate-bound forms were obtained and showed that in the presence of isethionate, OaIseP adopts a closed conformation whereby two domains of the protein fold over the substrate. We serendipitously discovered two crystal forms with sulfonate-containing buffers (HEPES and MES) bound in the isethionate-binding site. However, these do not evoke domain closure, presumably because of the larger ligand size. Together, our data elucidate the molecular details of how a TRAP substrate-binding protein binds a sulfonate-containing substrate, rather than a typical carboxylate-containing substrate. These results may inform future antibiotic development to target TRAP transporters and provide insights into protein engineering of TRAP transporter substrate-binding proteins.

Indexed as

Bacterial ProteinsBinding SitesCrystallography, X-RayPeriplasmic Binding ProteinsProtein BindingSubstrate SpecificityBacterial ProteinsPeriplasmic Binding Proteinsbacterial sulfur metabolismDesulfovibrioisethionateOleidesulfovibrio alaskensissubstrate-binding proteinstripartite ATP-independent periplasmic trap) transporters

Identifiers

PMID39560287
PMCPMC11668362

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.